Medicaid Buy-In: Is it the Next Frontier?
Tuesday, October 24th
1:30PM-3:00PM
The idea of offering Medicaid as an option that people with higher incomes could purchase has been a topic of discussion recently. Could it be a solution for consumers who live in areas that commercial insurance carriers do not serve through the exchange, known as “bare counties” since Medicaid has a statewide reach and contracts with providers everywhere? Could it become a public option and provide consumers more choices? The concept is being considered by a U. S. Senator and was explored in Nevada where the state legislature passed a law in 2016 to offer Medicaid as a buy-in that was ultimately vetoed. After hearing a state and federal legislative perspective and thoughts from a national expert on the issue, there will be opportunity for thoughtful discussion. What are the potential advantages to a state in offering a Medicaid buy-in? What are the disadvantages or potential insurance market implications? What are some of the challenges in enacting and implementing this option?
Speakers:
- Aimee Grace, Health Policy Advisor, Office of Senator Brian Schatz, State of Hawaii
Cindy Mann, Partner, Manatt Health
- Assemblyman Mike Sprinkle, Representing Assembly District 30, State of Nevada



For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 























































































































































